Skip to main content
Premium Trial:

Request an Annual Quote

Galileo Genomics Moves to IBM Servers

NEW YORK (GenomeWeb News) Oct. 1 - Galileo Genomics of Montreal has chosen IBM servers for its laboratory, business, and clinical applications, IBM said today.

 

In addition to using IBM's LIMS system for its lab and eServer for business applications, Galileo is using IBM's eServer xSeries, which runs Linux, to analyze genetic data from the Quebec founder population. This study examines samples from a population of six million Quebec residents who are all distant relatives, for genetic factors implicated in diabetes, asthma, and schizophrenia. The clustering technology in the xSeries is designed to enable Galileo to distribute processing power among all its servers in order to shorten processing of the data in this sample.

 

Jean-François Lévesque, Galileo's director of IT, said the company switched to IBM servers because it has grown from 15 to more than 80 employees in the past two years, and that its 'white box' servers "had reached its capacity to support our discovery process."

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.